NCT00113178View on ClinicalTrials.gov

Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

June 30, 2005

Conditions
Atrial Flutter
Interventions
DEVICE

Catheter-based cardiac cryoablation

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT00113178 - Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter | Biotech Hunter | Biotech Hunter